Table content
**Cooper Companies Stock Falls Sharply After Unimpressive Financial Statement**
**Released:** March 7, 2025, 12:45 PM EST
**Main Points:**
* Following the medical equipment company’s announcement of quarterly sales that were less than anticipated, Cooper Companies’ shares fell precipitously on Friday.
TruBit Collaborates with Morpho to Introduce DeFi Unearned Revenue in Latin America
* Despite increasing its yearly profit prediction, Cooper’s share value dropped to its lowest point since November 2023. The sales prediction may have alarmed investors.
* Cooper Companies, which conducts business through two segments, CooperVision and CooperSurgical, has seen its share value decrease by about 18% over the previous year.
Shares of Cooper Companies (COO), a manufacturer of medical equipment, fell 8% on Friday after the business revealed quarterly sales data that were lower than expected.
The business announced adjusted earnings per share (EPS) of $0.92 for the first fiscal quarter of 2025, which was in line with analysts’ predictions as compiled by Visible Alpha. Revenue, however, was $964.7 million, a 5% increase year over year, but still fell short of forecasts.
Despite the California-based company raising its full-year earnings forecast to an adjusted EPS range of $3.94 to $4.02 (up from $3.92 to $4.02), the share value continued to decline. While the range’s midpoint is marginally lower than anticipated, it is still within the $3.99 general consensus.
According to CEO Al White, the business fulfilled its revenue goals and surpassed its operational objectives. Cooper Companies, with its CooperVision and CooperSurgical divisions, also anticipates total revenue for fiscal year 2025 to be between $4.08 billion and $4.16 billion, a 6% to 8% increase year over year. According to Visible Alpha, analysts had predicted $4.1 billion.
During Friday’s trading session, Cooper Companies’ share value reached its lowest level since November 2023 and has shed about 18% of its value over the past year.
To guarantee the trustworthiness of data, Investopedia obligates writers to mention direct origins, like state statistics, authorized accounts, discussions with business specialists, and unique coverage. We additionally seek advice from unique inquiries from other trustworthy journals where pertinent. You could discover greater approximately our standards for generating unbiased, correct content material in our editorial guidelines.
